Alnylam Pharmaceuticals (ALNY) Net Shares Issued and Repurchased (2012 - 2018)

Alnylam Pharmaceuticals (ALNY) has reported Net Shares Issued and Repurchased for 7 consecutive years, with $2.3 million the latest figure, recorded in Q4 2018.

• For the quarter ending Q4 2018, Net Shares Issued and Repurchased rose 36.6% year-over-year to $2.3 million; the trailing twelve-month figure through Dec 2018 stood at $2.3 million (up 36.6% YoY), and the FY2018 full-year result was $2.3 million, up 36.6% from the prior year.
• Net Shares Issued and Repurchased improved to $2.3 million in Q4 2018 per ALNY's latest filing, from $1.7 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $2.5 million in Q4 2016 and bottomed at $85000.0 in Q4 2014.
• Historically, Net Shares Issued and Repurchased has averaged $1.3 million across 5 years, with a median of $1.7 million in 2017.
• The sharpest annual moves came in 2016 and 2017: Net Shares Issued and Repurchased soared 1339.55% in 2016, then sank 34.69% in 2017.
• Over 5 years, Net Shares Issued and Repurchased stood at $85000.0 in 2014, then soared by 108.24% to $177000.0 in 2015, then jumped by 1339.55% to $2.5 million in 2016, then sank by 34.69% to $1.7 million in 2017, then jumped by 36.6% to $2.3 million in 2018.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $2.3 million, $1.7 million, and $2.5 million for Q4 2018, Q4 2017, and Q4 2016 respectively.